Canada markets closed

Tarsus Pharmaceuticals, Inc. (TARS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
37.00+2.96 (+8.70%)
At close: 04:00PM EDT
37.65 +0.65 (+1.76%)
After hours: 07:44PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-63,343
-135,893
-62,091
-13,827
-26,811
Depreciation & amortization
267
877
325
312
96
Stock based compensation
11,968
19,830
13,460
8,455
839
Change in working capital
-999
306
-951
1,372
1,458
Accounts receivable
-27,385
-16,621
0
-
-
Inventory
-4,036
-3,107
0
-
-
Accounts Payable
1,544
13,240
821
3,880
3,240
Other working capital
-50,930
-122,995
-49,536
3,162
-21,594
Other non-cash items
690
926
773
5,790
3,280
Net cash provided by operating activites
-50,277
-117,493
-49,030
3,748
-21,138
Cash flows from investing activities
Investments in property, plant and equipment
-653
-5,502
-506
-586
-456
Purchases of investments
-104,547
-28,664
-149,438
0
-
Sales/Maturities of investments
136,969
174,770
5,315
0
-
Net cash used for investing activites
-57,684
140,604
-144,629
-586
-456
Cash flows from financing activities
Common stock issued
74,352
118,599
74,352
0
91,673
Common stock repurchased
-
-
-
-
-28
Other financing activites
-
-
-950
-303
91,683
Net cash used privided by (used for) financing activities
93,649
130,176
93,987
21
131,771
Net change in cash
-14,312
153,287
-99,672
3,183
110,177
Cash at beginning of period
183,801
71,660
171,332
168,149
57,972
Cash at end of period
169,489
224,947
71,660
171,332
168,149
Free Cash Flow
Operating Cash Flow
-50,277
-117,493
-49,030
3,748
-21,138
Capital Expenditure
-653
-5,502
-506
-586
-456
Free Cash Flow
-50,930
-122,995
-49,536
3,162
-21,594